ptld
Showing 1 - 3 of 3
PTLD, CAEBV, HLH Trial in Beijing (low-dose CD20 mAb injection)
Enrolling by invitation
- PTLD
- +2 more
- low-dose CD20 monoclonal antibody injection
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Feb 24, 2022
Post-transplant Lymphoproliferative Disorder, PTLD Trial (Obinutuzumab)
Withdrawn
- Post-transplant Lymphoproliferative Disorder
- PTLD
- (no location specified)
Mar 16, 2017
PTLD, Posttransplant Lymphoproliferative Disorder Trial in Worldwide (rituximab monotherapy, sequential R-CHOP)
Completed
- PTLD
- Posttransplant Lymphoproliferative Disorder
- rituximab monotherapy
- sequential R-CHOP
-
Brisbane, Australia
- +6 more
Mar 6, 2017